A randomized placebo-controlled phase 3 trial of an antisense oligonucleotide, drisapersen, in Duchenne muscular dystrophyNathalie Goemans, Yasuhiro Takeshima, Eugenio Mercuri et al.|Neuromuscular Disorders|2017Cited by 128
Association of Dermatomyositis Sine Dermatitis With Anti–Nuclear Matrix Protein 2 AutoantibodiesMichio Inoue, Ichizo Nishino, Takashi Tajima et al.|JAMA Neurology|2020Cited by 70
Muscle glycogen storage disease 0 presenting recurrent syncope with weakness and myalgiaSayuri Sukigara, Ichizo Nishino, Wen‐Chen Liang et al.|Neuromuscular Disorders|2011Cited by 47